FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology and aims at prognosing risk of optic neuropathy at normal tension glaucoma. Retinal thickness is measured in temporal external and inferior external portions of macula. If thickness of retina comes to ≤210 mcm in temporal external and inferior external portions of macula, a risk of optic neuropathy at normal tension glaucoma is prognosed.
EFFECT: method provides higher prognosis accuracy.
1 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF NORMAL TENSION GLAUCOMA | 2015 |
|
RU2573336C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING LOW-PRESSURE GLAUCOMA | 2023 |
|
RU2823133C1 |
| METHOD FOR EARLY DIAGNOSIS OF LOW-TENSION GLAUCOMA | 2023 |
|
RU2816038C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING LOW-TENSION GLAUCOMA BY OPTICAL COHERENCE TOMOGRAPHY WITH ANGIOGRAPHY | 2023 |
|
RU2815155C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF OPTICAL NEUROPATHY IN PRIMARY OPEN-ANGLE GLAUCOMA | 2019 |
|
RU2706956C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF MYOPIA AND GLAUCOMA ASSOCIATED WITH MYOPIA | 2018 |
|
RU2700671C1 |
| METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
| METHOD FOR PREDICTING THE RISK OF PRIMARY OPEN-ANGLE GLAUCOMA | 2020 |
|
RU2752031C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING LOW-TENSION GLAUCOMA | 2023 |
|
RU2816039C1 |
| METHOD OF DETERMINING INDICATIONS FOR TREATMENT OF OPHTHALMOLOGICAL COMPLICATIONS OF SYSTEMIC ATHEROSCLEROSIS | 2012 |
|
RU2494679C1 |
